{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:22:50Z","timestamp":1778300570429,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pntd.0008298","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000}}],"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPPGH5342"],"award-info":[{"award-number":["OPPGH5342"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0008298","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T17:33:18Z","timestamp":1591637598000},"page":"e0008298","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7197-6340","authenticated-orcid":true,"given":"Christine L.","family":"Dubray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita D.","family":"Sircar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery Madsen","family":"Beau de Rochars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8053-6603","authenticated-orcid":true,"given":"Joshua","family":"Bogus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel N.","family":"Direny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Romuald","family":"Ernest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl R.","family":"Fayette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2682-7316","authenticated-orcid":true,"given":"Charles W.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2471-6700","authenticated-orcid":true,"given":"Marisa","family":"Hast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kobie","family":"O\u2019Brian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy Emmanuel","family":"Pavilus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6022-3925","authenticated-orcid":true,"given":"Daniel Frantz","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan E.","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary J.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Frantz","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"pntd.0008298.ref001","first-page":"w13727","article-title":"Neglected tropical diseases: diagnosis, clinical management, treatment and control","volume":"142","author":"J Utzinger","year":"2012","journal-title":"Swiss medical weekly"},{"key":"pntd.0008298.ref002","unstructured":"World Health Organization (1997). Elimination of lymphatic filariasis as a public health problem\u2014resolution of the executive board of the WHO. Available from: http:\/\/www.who.int\/neglected_diseases\/mediacentre\/WHA_50.29_Eng.pdf"},{"key":"pntd.0008298.ref003","unstructured":"World Health Organisation (2018). Global Programme to Eliminate Lymphatic Filariasis. Available from: http:\/\/www.who.int\/lymphatic_filariasis\/elimination-programme\/en\/."},{"issue":"48","key":"pntd.0008298.ref004","first-page":"478","article-title":"Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement","volume":"87","year":"2012","journal-title":"Releve epidemiologique hebdomadaire \/ Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record \/ Health Section of the Secretariat of the League of Nations"},{"issue":"41","key":"pntd.0008298.ref005","first-page":"457","article-title":"Global programme to eliminate lymphatic filariasis: progress report, 2018","volume":"94","author":"World Health Organization","year":"2019","journal-title":"Releve epidemiologique hebdomadaire \/ Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record \/ Health Section of the Secretariat of the League of Nations"},{"issue":"19","key":"pntd.0008298.ref006","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1706854","article-title":"A Trial of a Triple-Drug Treatment for Lymphatic Filariasis","volume":"379","author":"CL King","year":"2018","journal-title":"The New England journal of medicine"},{"key":"pntd.0008298.ref007","article-title":"Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis","author":"EK Thomsen","year":"2015","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"5","key":"pntd.0008298.ref008","doi-asserted-by":"crossref","first-page":"e0007325","DOI":"10.1371\/journal.pntd.0007325","article-title":"Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Cote d'Ivoire","volume":"13","author":"C Edi","year":"2019","journal-title":"PLoS neglected tropical diseases"},{"issue":"4","key":"pntd.0008298.ref009","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1473-3099(16)30467-4","article-title":"Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study","volume":"17","author":"MA Irvine","year":"2017","journal-title":"The Lancet Infectious diseases"},{"key":"pntd.0008298.ref010","unstructured":"World Health Organisation (2006). The safety of medicines in public health programmes: pharmacovigilance an essential tool. Available from: http:\/\/www.who.int\/medicines\/areas\/quality_safety\/safety_efficacy\/Pharmacovigilance_B.pdf."},{"issue":"12","key":"pntd.0008298.ref011","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11593830-000000000-00000","article-title":"Modified prescription-event monitoring studies: a tool for pharmacovigilance and risk management","volume":"34","author":"D Layton","year":"2011","journal-title":"Drug safety"},{"issue":"5","key":"pntd.0008298.ref012","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4269\/ajtmh.2005.73.888","article-title":"The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration","volume":"73","author":"MB de Rochars","year":"2005","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"7","key":"pntd.0008298.ref013","doi-asserted-by":"crossref","first-page":"e2915","DOI":"10.1371\/journal.pntd.0002915","article-title":"Haiti National Program for the elimination of lymphatic filariasis\u2014a model of success in the face of adversity","volume":"8","author":"R Oscar","year":"2014","journal-title":"PLoS neglected tropical diseases"},{"issue":"4_Suppl","key":"pntd.0008298.ref014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4269\/ajtmh.16-0669","article-title":"Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti","volume":"97","author":"PJ Lammie","year":"2017","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"6","key":"pntd.0008298.ref015","doi-asserted-by":"crossref","first-page":"e1002839","DOI":"10.1371\/journal.pmed.1002839","article-title":"The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study","volume":"16","author":"GJ Weil","year":"2019","journal-title":"PLoS medicine"},{"issue":"5","key":"pntd.0008298.ref016","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4269\/ajtmh.13-0245","article-title":"Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen","volume":"89","author":"CB Chesnais","year":"2013","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"9","key":"pntd.0008298.ref017","doi-asserted-by":"crossref","first-page":"e0005703","DOI":"10.1371\/journal.pntd.0005703","article-title":"A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa","volume":"11","author":"CB Chesnais","year":"2017","journal-title":"PLoS neglected tropical diseases"},{"key":"pntd.0008298.ref018","unstructured":"National Cancer Institute (2017) NCI Common Terminology Criteria for Adverse Events (CTCAE) v.5.0. Available at https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed 04 June 2018."},{"issue":"4","key":"pntd.0008298.ref019","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/2229-3485.167101","article-title":"Clinical Data Acquisition Standards Harmonization importance and benefits in clinical data management","volume":"6","author":"JR Gaddale","year":"2015","journal-title":"Perspectives in clinical research"},{"key":"pntd.0008298.ref020","unstructured":"Medical Dictionary for Regulatory Activities [cited 2017 Feb 3]. Available from: https:\/\/www.meddra.org\/."},{"key":"pntd.0008298.ref021","article-title":"Part I\u2014Ectoparasites: Scabies","author":"C Thomas","year":"2019","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"pntd.0008298.ref022","first-page":"Cd007745","article-title":"Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection","author":"C Henriquez-Camacho","year":"2016","journal-title":"Cochrane database of systematic reviews (Online)"},{"issue":"5","key":"pntd.0008298.ref023","doi-asserted-by":"crossref","first-page":"e0006454","DOI":"10.1371\/journal.pntd.0006454","article-title":"Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature","volume":"12","author":"PJ Budge","year":"2018","journal-title":"PLoS neglected tropical diseases"},{"issue":"5","key":"pntd.0008298.ref024","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2003.68.568","article-title":"Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000","volume":"68","author":"SI McLaughlin","year":"2003","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"9076","key":"pntd.0008298.ref025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(97)02231-9","article-title":"Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children","volume":"350","author":"DG Addiss","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"pntd.0008298.ref026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.1991.44.3","article-title":"Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti","volume":"44","author":"FO Richards","year":"1991","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"1","key":"pntd.0008298.ref027","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12889-017-4414-5","article-title":"A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa","volume":"17","author":"A Silumbwe","year":"2017","journal-title":"BMC public health"},{"issue":"11","key":"pntd.0008298.ref028","doi-asserted-by":"crossref","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","article-title":"A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","volume":"7","author":"A Krentel","year":"2013","journal-title":"PLoS neglected tropical diseases"},{"issue":"4","key":"pntd.0008298.ref029","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed3040122","article-title":"Eliminating Neglected Tropical Diseases in Urban Areas: A Review of Challenges, Strategies and Research Directions for Successful Mass Drug Administration","volume":"3","author":"AM Adams","year":"2018","journal-title":"Tropical medicine and infectious disease"},{"issue":"10","key":"pntd.0008298.ref030","doi-asserted-by":"crossref","first-page":"e1807","DOI":"10.1371\/journal.pntd.0001807","article-title":"Secondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settings","volume":"6","author":"N Drexler","year":"2012","journal-title":"PLoS neglected tropical diseases"},{"key":"pntd.0008298.ref031","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1186\/s13071-015-1235-1","article-title":"Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases","volume":"8","author":"TD Hollingsworth","year":"2015","journal-title":"Parasites & vectors"},{"issue":"7","key":"pntd.0008298.ref032","doi-asserted-by":"crossref","first-page":"e0007541","DOI":"10.1371\/journal.pntd.0007541","article-title":"Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach","volume":"13","author":"CW Goss","year":"2019","journal-title":"PLoS neglected tropical diseases"},{"key":"pntd.0008298.ref033","volume-title":"Guideline: Alternative Mass Drug Administration Regimens to Eliminate Lymphatic Filariasis","author":"WHO Guidelines Approved by the Guidelines Review Committee","year":"2017"},{"issue":"40","key":"pntd.0008298.ref034","first-page":"589","article-title":"Summary of global update on preventive chemotherapy implementation in 2016: crossing the billion","volume":"92","year":"2017","journal-title":"Releve epidemiologique hebdomadaire \/ Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record \/ Health Section of the Secretariat of the League of Nations"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0008298","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T20:37:01Z","timestamp":1592512621000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008298"}},"subtitle":[],"editor":[{"given":"Subash","family":"Babu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008298","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0008298","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]}}}